Type-2-Diabetes: Canagliflozin reduces cardiovascular Risk

被引：0

|

作者：

Lichert, Frank

机构：

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2017年 / 142卷 / 22期

关键词：

D O I：

10.1056/NEJMoa.1611925

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1647 / 1647

页数：1

相关论文

共 50 条

[1] Type-2-Diabetes: Good Glucose Control initially reduces cardiovascular Risk
Ritzel, Robert
DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 (04) : 272 - 272
[2] Type-2-Diabetes Breastfeeding reduces the maternal Disease Risk?
Schulz-Hanke, Ines
GESUNDHEITSWESEN, 2014, 76 (11) : 691 - 691
[3] Efficacy and Safety of Canagliflozin in Patients with Type-2-Diabetes treated with insulin
Kahl, S.
DIABETOLOGE, 2015, 11 (01): : 66 - 67
[4] Canagliflozin and cardiovascular outcomes in Type 2 diabetes
Sarraju, Ashish
Spencer-Bonilla, Gabriela
Rodriguez, Fatima
Mahaffey, Kenneth W.
FUTURE CARDIOLOGY, 2020, 17 (01) : 39 - 48
[5] Type-2-Diabetes: Intensive Therapy reduces Mortality
Keuthage, Winfried
DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (05) : 287 - 287
[6] Type-2-Diabetes: Pioglitazone reduces Atheroma volume
Keuthage, Winfried
DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (05) : 282 - 282
[7] Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
Budoff, Matthew J.
Wilding, John P. H.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
[8] Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
Skelley, Jessica W.
Carter, Brooke S.
Roberts, Megan Z.
VASCULAR HEALTH AND RISK MANAGEMENT, 2018, 14 : 419 - 428
[9] Cancers increase the Risk of Type-2-Diabetes
Lichert, Frank
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (11): : 1330 - +
[10] Coffee Consumption and Risk of Type-2-Diabetes
Jecht, M.
DIABETOLOGE, 2014, 10 (02): : 136 - 137

← 1 2 3 4 5 →